Search research articles
Contact Us
Filters
Showing results (631-640 of 765) with videos related to
Page
of 77
Sort By:
American Heart Journal
|
April 10, 2020
COMPARison of pre-hospital CRUSHed vs. uncrushed Prasugrel tablets in patients with STEMI undergoing primary percutaneous coronary interventions: Rationale and design of the COMPARE CRUSH trial
Georgios J Vlachojannis, Rosanne F Vogel, Jeroen M Wilschut, et al.
Clinical Pharmacology and Therapeutics
|
August 28, 2025
Impact of Race on Profiles of Platelet Reactivity and Clinical Outcomes in Clopidogrel-Treated Participants
Luis Ortega-Paz, Cameron D Thomas, Claudio Laudani, et al.
Nature Reviews. Cardiology
|
July 6, 2018
Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention
Davide Capodanno, Roxana Mehran, Marco Valgimigli, et al.
Circulation. Cardiovascular Interventions
|
May 24, 2012
Pharmacokinetic and pharmacodynamic effects of elinogrel: results of the platelet function substudy from the intravenous and oral administration of elinogrel to evaluate tolerability and efficacy in nonurgent percutaneous coronary intervention patients (INNOVATE-PCI) trial
Dominick J Angiolillo, Robert C Welsh, Dietmar Trenk, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
October 10, 2020
Comparative influence of bleeding and ischemic risk factors on diabetic patients undergoing percutaneous coronary intervention with everolimus-eluting stents
Ridhima Goel, Davide Cao, Rishi Chandiramani, et al.
Circulation
|
December 14, 2020
Effect of Prehospital Crushed Prasugrel Tablets in Patients With ST-Segment-Elevation Myocardial Infarction Planned for Primary Percutaneous Coronary Intervention: The Randomized COMPARE CRUSH Trial
Georgios J Vlachojannis, Jeroen M Wilschut, Rosanne F Vogel, et al.
Journal of Thrombosis and Thrombolysis
|
March 12, 2021
Impact of renal function in high bleeding risk patients undergoing percutaneous coronary intervention: a patient-level stratified analysis from four post-approval studies
Toshiki Kuno, Bimmer Claessen, Davide Cao, et al.
JAMA Cardiology
|
September 27, 2019
Benefit and Risks of Aspirin in Addition to Ticagrelor in Acute Coronary Syndromes: A Post Hoc Analysis of the Randomized GLOBAL LEADERS Trial
Mariusz Tomaniak, Ply Chichareon, Yoshinobu Onuma, et al.
The American Journal of Cardiology
|
October 9, 2007
Meta-analysis appraising high clopidogrel loading in patients undergoing percutaneous coronary intervention
Marzia Lotrionte, Giuseppe G L Biondi-Zoccai, Pierfrancesco Agostoni, et al.
Journal of the American Heart Association
|
July 4, 2025
<i>CYP2C19</i> Phenotype, P2Y<sub>12</sub> Inhibitor Selection, and Clinical Outcomes in Patients on Maintenance Clopidogrel Therapy
Rajiv C Patel, Cameron D Thomas, Joseph S Rossi, et al.
Page
of 77
Search research articles
Search
Showing results (631-640 of 765) with videos related to
Sort By:
Page
of 77
American Heart Journal
|
April 10, 2020
COMPARison of pre-hospital CRUSHed vs. uncrushed Prasugrel tablets in patients with STEMI undergoing primary percutaneous coronary interventions: Rationale and design of the COMPARE CRUSH trial
Georgios J Vlachojannis, Rosanne F Vogel, Jeroen M Wilschut, et al.
Clinical Pharmacology and Therapeutics
|
August 28, 2025
Impact of Race on Profiles of Platelet Reactivity and Clinical Outcomes in Clopidogrel-Treated Participants
Luis Ortega-Paz, Cameron D Thomas, Claudio Laudani, et al.
Nature Reviews. Cardiology
|
July 6, 2018
Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention
Davide Capodanno, Roxana Mehran, Marco Valgimigli, et al.
Circulation. Cardiovascular Interventions
|
May 24, 2012
Pharmacokinetic and pharmacodynamic effects of elinogrel: results of the platelet function substudy from the intravenous and oral administration of elinogrel to evaluate tolerability and efficacy in nonurgent percutaneous coronary intervention patients (INNOVATE-PCI) trial
Dominick J Angiolillo, Robert C Welsh, Dietmar Trenk, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
October 10, 2020
Comparative influence of bleeding and ischemic risk factors on diabetic patients undergoing percutaneous coronary intervention with everolimus-eluting stents
Ridhima Goel, Davide Cao, Rishi Chandiramani, et al.
Circulation
|
December 14, 2020
Effect of Prehospital Crushed Prasugrel Tablets in Patients With ST-Segment-Elevation Myocardial Infarction Planned for Primary Percutaneous Coronary Intervention: The Randomized COMPARE CRUSH Trial
Georgios J Vlachojannis, Jeroen M Wilschut, Rosanne F Vogel, et al.
Journal of Thrombosis and Thrombolysis
|
March 12, 2021
Impact of renal function in high bleeding risk patients undergoing percutaneous coronary intervention: a patient-level stratified analysis from four post-approval studies
Toshiki Kuno, Bimmer Claessen, Davide Cao, et al.
JAMA Cardiology
|
September 27, 2019
Benefit and Risks of Aspirin in Addition to Ticagrelor in Acute Coronary Syndromes: A Post Hoc Analysis of the Randomized GLOBAL LEADERS Trial
Mariusz Tomaniak, Ply Chichareon, Yoshinobu Onuma, et al.
The American Journal of Cardiology
|
October 9, 2007
Meta-analysis appraising high clopidogrel loading in patients undergoing percutaneous coronary intervention
Marzia Lotrionte, Giuseppe G L Biondi-Zoccai, Pierfrancesco Agostoni, et al.
Journal of the American Heart Association
|
July 4, 2025
<i>CYP2C19</i> Phenotype, P2Y<sub>12</sub> Inhibitor Selection, and Clinical Outcomes in Patients on Maintenance Clopidogrel Therapy
Rajiv C Patel, Cameron D Thomas, Joseph S Rossi, et al.
Page
of 77